We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOC
12751
DELISTED
Biocept, Inc.
BIOC
$45K ﹤0.01%
634
-1,231
-66% -$96.7K
SSAAW
12752
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$45K ﹤0.01%
200,932
-23,975
-11% -$9.94K
AAQC.WS
12753
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$45K ﹤0.01%
116,830
+6,082
+5% +$3.12K
NBEV
12754
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$45K ﹤0.01%
76,778
-6,310
-8% -$4.51K
ADTX
12755
CALL
DELISTED
ADITXT INC
ADTX
0
CRDL
12756
Cardiol Therapeutics
CRDL
$164M
$44K ﹤0.01%
28,452
-148,617
-84% -$245K
CTMX icon
12757
CALL
CytomX Therapeutics
CTMX
$754M
$44K ﹤0.01%
16,600
-18,700
-53% -$71.8K
DYAI icon
12758
Dyadic International
DYAI
$36.4M
$44K ﹤0.01%
+14,563
New +$54.6K
LITS
12759
CALL
Lite Strategy Inc
LITS
$30.9M
$44K ﹤0.01%
3,655
+1,520
+71% +$59.7K
MESO
12760
PUT
Mesoblast
MESO
$2.07B
$44K ﹤0.01%
5,250
-600
-10% -$5.1K
MPU icon
12761
Mega Matrix
MPU
$13.7M
$44K ﹤0.01%
+22,024
New +$124K
VATE icon
12762
CALL
INNOVATE Corp
VATE
$165M
$44K ﹤0.01%
1,200
-1,410
-54% -$52.3K
MKFG
12763
PUT
DELISTED
Markforged Holding Corporation
MKFG
$44K ﹤0.01%
1,110
-1,640
-60% -$71.8K
VIEW
12764
PUT
DELISTED
View, Inc. Class A Common Stock
VIEW
$44K ﹤0.01%
395
+60
+18% +$9.07K
EGLX
12765
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$44K ﹤0.01%
18,079
-49,636
-73% -$132K
WLMS
12766
DELISTED
Williams Industrial Services Group Inc.
WLMS
$44K ﹤0.01%
+22,163
New +$46.3K
OBSV
12767
PUT
DELISTED
ObsEva SA Ordinary Shares
OBSV
$44K ﹤0.01%
29,200
-29,000
-50% -$42.8K
IO
12768
DELISTED
ION Geophysical Corporation
IO
$44K ﹤0.01%
+50,699
New +$39.9K
AQMS icon
12769
CALL
Aqua Metals
AQMS
$10.2M
$43K ﹤0.01%
143
-72
-33% -$16.3K
FABC
12770
PUT
Fabric.AI Inc
FABC
$18.4M
$43K ﹤0.01%
259
-11
-4% -$1.82K
ENTX icon
12771
Entera Bio
ENTX
$141M
$43K ﹤0.01%
15,057
-12,531
-45% -$30.1K
ETNB
12772
PUT
DELISTED
89bio
ETNB
$43K ﹤0.01%
+11,400
New +$73.4K
LCTX icon
12773
CALL
Lineage Cell Therapeutics
LCTX
$278M
$43K ﹤0.01%
27,600
-22,300
-45% -$34.6K
PPTA
12774
PUT
Perpetua Resources
PPTA
$3.09B
$43K ﹤0.01%
10,600
-13,200
-55% -$52.8K
SYPR icon
12775
CALL
Sypris Solutions
SYPR
$46.7M
$43K ﹤0.01%
16,000
+2,600
+19% +$6.1K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.